DE SCR52

Designates February 15, 2025, as "Angelman Syndrome Awareness Day" in Delaware, aligning with International Angelman Day observed worldwide

Angelman syndrome is a rare neuro-genetic disorder occurring in 1 in 15,000 live births, affecting approximately 500,000 individuals globally

The disorder is caused by loss of function of the UBE3A gene on the 15th chromosome inherited from the mother, resulting in developmental delays, speech and balance problems, mental disability, and sometimes seizures

Symptoms typically appear between 6 and 12 months of age, and the condition shares characteristics with autism, cerebral palsy, and Prader-Willi syndrome

The resolution affirms the importance of raising awareness to ensure effective screening, diagnosis, and treatment, noting there is currently no cure but research continues